chronic myeloproliferative disorder: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1236 |
4. Check minimum number of eventsNone |
1236 |
5. Include endpointsNone |
1236 |
6. Filter based on genotype QC (FinnGen only) |
1236 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Polycythaemia vera
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8645 | 4398 | 4141 |
| Only index persons | 6571 | 3383 | 3188 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.13 | 0.12 |
| Only index persons | 0.12 | 0.12 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 67.45 | 69.26 | 65.58 |
| Only index persons | 67.11 | 69.04 | 65.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1236 | 594 | 642 |
| Unadjusted period prevalence (%) | 0.24 | 0.20 | 0.28 |
| Median age at first event (years) | 65.55 | 64.99 | 66.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1118
- Matched controls
- 11179
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D45
ICD-10 Finland
Polycythaemia vera
4503599627370496.0
323.0
1091
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
511.3
323.0
754
45
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
323.0
310
*
L01XX05
ATC
hydroxycarbamide; oral
648.3
323.0
687
27
TPH00
NOMESCO Finland
Phlebotomy
1649.6
323.0
344
*
SPAT1074
SPAT
Venesection
598.6
249.0
238
5
XW000
NOMESCO Finland
Bone marrow biopsy
34.1
226.5
300
119
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
66.4
167.8
193
35
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
201.3
138.1
141
8
D75.2
ICD-10 Finland
Essential thrombocytosis
67.8
115.1
132
22
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
112.4
106
*
B99
ICPC
Blood/lymph/spleen disease other
95.5
94.9
104
12
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
47.3
90.9
111
26
D75.1
ICD-10 Finland
Secondary polycythaemia
61.7
78.2
91
16
M04AA01
ATC
allopurinol; systemic
4.2
71.0
320
974
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
83.9
70.0
78
10
L03AB04
ATC
interferon alfa-2a; parenteral
710.0
68.8
67
*
L01XX35
ATC
anagrelide; oral
128.1
67.7
72
6
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
64.2
61
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
218.5
60.7
62
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
57.6
244
686
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
56.7
54
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
575.6
56.1
55
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
152.7
55.4
58
*
174
Kela drug reimbursment
Ruxolitinib
520.5
50.8
50
*
374
Kela drug reimbursment
Ruxolitinib
476.7
46.6
46
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
49.0
46.5
56
12
L01XE18
ATC
[U] ruxolitinib; oral
+∞
39.8
38
*
212
Kela drug reimbursment
Gout
9.7
39.8
83
92
L01EJ01
ATC
ruxolitinib; oral
400.9
39.3
39
*
WW500
NOMESCO Finland
Blood transfusion
9.4
37.8
80
91
130
Kela drug reimbursment
Malignant tumour
+∞
37.7
36
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
37.5
157
425
D75.0
ICD-10 Finland
Familial erythrocytosis
85.1
37.0
41
5
116
Kela drug reimbursment
Prostate cancer
+∞
36.7
35
*
B74
ICPC
Malignant neoplasm blood other
357.9
35.1
35
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
53.1
34.6
41
8
B28
ICPC
Limited function/disability (B)
29.9
34.5
46
16
H02AB02
ATC
dexamethasone; systemic
15.7
32.9
54
36
115
Kela drug reimbursment
Breast cancer
+∞
32.4
31
*
B01AB05
ATC
enoxaparin; parenteral
2.3
32.1
381
2039
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
30.3
29
*
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
159.2
29.8
31
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
29.3
539
3464
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
29.3
28
*
B04
ICPC
Blood symptom/complaint
25.2
28.0
39
16
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
25.1
24
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
132.9
24.7
26
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
24.0
23
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.9
23.9
80
172
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
23.0
22
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
21.9
21
*
TPH00
SPAT
NA
224.1
21.7
22
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
44.3
21.5
26
6
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
42.5
20.5
25
6
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
49.0
20.2
24
5
WF002
NOMESCO Finland
Radical radiotherapy
36.5
19.9
25
7
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
19.8
19
*
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
22.0
19.6
28
13
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
B75
ICPC
Neoplasm blood benign/unspecified
193.1
18.6
19
*
L02AE02
ATC
leuprorelin; implant, parenteral
44.8
18.3
22
5
A04AA01
ATC
ondansetron; systemic, rectal
6.1
18.0
49
83
R50.9
ICD-10 Finland
Fever, unspecified
2.5
17.9
151
658
JN4BD
NOMESCO Finland
Extensive body CT
3.5
17.8
85
255
XX3DW
NOMESCO Finland
Time consuming IT work
3.8
17.8
78
218
C90.0
ICD-10 Finland
Multiple myeloma
+∞
17.8
17
*
L03AA04
ATC
NA
182.7
17.6
18
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
17.5
110
402
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
17.3
17.4
27
16
Z51.5
ICD-10 Finland
Palliative care
5.3
17.0
52
102
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
16.7
16
*
L01AB01
ATC
busulfan; systemic
+∞
16.7
16
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.7
16
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
16.7
16
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
16.6
93
312
HAC20
NOMESCO Finland
Total mastectomy
91.4
16.6
18
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
172.4
16.5
17
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
172.4
16.5
17
*
I81
ICD-10 Finland
Portal vein thrombosis
23.4
16.5
23
10
ZX120
NOMESCO Finland
Intravenous
2.9
16.2
102
373
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
60.9
15.8
18
*
G04BE03
ATC
sildenafil; oral
33.9
15.8
20
6
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.7
15
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
29.0
15.2
20
7
L02BG04
ATC
letrozole; oral
23.7
15.1
21
9
L57.0
ICD-10 Finland
Actinic keratosis
2.6
15.1
117
485
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
14.9
145
675
ZX112
NOMESCO Finland
Subcutaneous
12.6
14.9
26
21
ZZR00
NOMESCO Finland
Flap of skin
12.6
14.9
26
21
D73.5
ICD-10 Finland
Infarction of spleen
57.5
14.8
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
14.7
144
675
B01AA03
ATC
warfarin; systemic
1.8
14.6
304
1918
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
14.6
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
Y77
ICPC
Malignant neoplasm prostate
151.9
14.5
15
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
151.9
14.5
15
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
151.9
14.5
15
*
A04AA02
ATC
granisetron; systemic, transdermal
36.5
14.5
18
5
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
4.6
14.1
48
107
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
12.9
13.9
24
19
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
13.9
103
414
NK6AN
NOMESCO Finland
Total body bone isotope imaging
30.4
13.9
18
6
JN4AD
NOMESCO Finland
Body CT examination
3.7
13.9
61
172
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
13.7
333
2198
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.6
13
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
13.6
13
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
13.6
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
13.5
129
597
PH_2
NOMESCO Finland
Other procedures on veins
141.6
13.5
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
13.3
258
1582
WF003
NOMESCO Finland
Adjuvant radiotherapy
32.4
12.6
16
5
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
12.5
12
*
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
+∞
12.5
12
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
12.3
77
282
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
6.7
12.1
30
46
N02AA05
ATC
oxycodone; systemic
2.1
12.0
145
744
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
11.9
220
1321
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
47.2
11.9
14
*
L03AA02
ATC
filgrastim; parenteral
30.4
11.7
15
5
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
11.5
11
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
11.5
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
121.2
11.4
12
*
HA1AA
NOMESCO Finland
X-ray mammography
4.2
11.3
42
103
ZY010
NOMESCO Finland
Hospital outpatient
3.5
11.1
51
150
B01AB10
ATC
tinzaparin; parenteral
3.0
11.1
64
223
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.9
11.0
35
73
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
9.3
11.0
22
24
JN4CD
NOMESCO Finland
Very extensive body CT
5.0
11.0
34
69
S97
ICPC
Chronic ulcer skin
2.6
10.8
79
317
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.8
228
1426
R71
ICD-10 Finland
Abnormality of red blood cells
18.0
10.7
16
9
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.0
10.7
18
14
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
60.6
10.6
12
*
B03XA02
ATC
darbepoetin alfa; parenteral
5.4
10.6
31
59
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.6
10.5
26
40
L02BB03
ATC
bicalutamide; oral
111.0
10.4
11
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
10.4
10
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
10.4
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.4
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.4
10
*
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.3
10.4
52
164
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.3
187
1112
Z3231
NOMESCO Finland
Registered nurse
1.6
10.2
279
1878
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
10.0
74
299
XQ848
NOMESCO Finland
Dermatological photography
4.6
9.9
33
73
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
26.3
9.8
13
5
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
9.6
53
180
K99
ICPC
Cardiovascular disease other
3.2
9.6
50
163
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
100.8
9.4
10
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
100.8
9.4
10
*
L02BA01
ATC
tamoxifen; oral
100.8
9.4
10
*
D58.2
ICD-10 Finland
Other haemoglobinopathies
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
9.3
97
468
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
9.2
164
971
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
9.1
74
315
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
24.2
8.9
12
5
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
50.4
8.7
10
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
50.4
8.7
10
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.2
8.6
31
75
M10.9
ICD-10 Finland
Gout, unspecified
2.2
8.6
91
440
I82.0
ICD-10 Finland
Budd-Chiari syndrome
90.7
8.4
9
*
L02BG03
ATC
anastrozole; oral
90.7
8.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
90.7
8.4
9
*
R04.0
ICD-10 Finland
Epistaxis
2.1
8.4
97
490
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
8.3
92
456
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
4.2
8.3
30
73
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
8.3
243
1657
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
11.8
8.1
14
12
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.6
8.0
55
215
J01DB01
ATC
cefalexin; oral
1.5
8.0
809
7143
C03DA01
ATC
spironolactone; oral
1.8
7.9
143
848
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
4.0
7.9
30
77
A46
ICD-10 Finland
Erysipelas
1.7
7.8
165
1027
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
7.8
74
343
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
7.7
130
754
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
45.3
7.7
9
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
45.3
7.7
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
18.5
7.6
11
6
D68.8
ICD-10 Finland
Other specified coagulation defects
7.2
7.5
17
24
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.5
154
952
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
80.6
7.4
8
*
B01AC14
ATC
[U] anagrelide; oral
+∞
7.3
7
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
7.2
147
904
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
7.2
44
163
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
30.2
7.2
9
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
20.2
7.1
10
5
C07AB07
ATC
bisoprolol; oral
1.4
7.1
556
4618
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.6
7.1
17
26
A07AA02
ATC
nystatin; oral
2.2
7.1
70
331
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
7.1
95
509
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.0
7.0
21
43
K93
ICPC
Pulmonary embolism
5.2
7.0
20
39
ZXC20
NOMESCO Finland
Use of chemical agents
4.7
6.9
22
48
SPAT1088
SPAT
Blood transfusion
13.9
6.9
11
8
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
6.8
186
1241
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.1
6.8
17
28
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.7
6.8
18
32
A79
ICPC
Malignancy NOS
40.3
6.8
8
*
K29
ICPC
Cardiovascular sympt/complt other
2.3
6.7
60
273
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
22.7
6.7
9
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.4
6.7
30
90
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.2
6.6
23
55
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
6.6
28
80
L71.9
ICD-10 Finland
Rosacea, unspecified
3.7
6.6
27
75
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.2
6.5
23
56
C03CA01
ATC
furosemide; systemic
1.4
6.5
360
2796
R06.0
ICD-10 Finland
Dyspnoea
1.5
6.5
259
1885
ZXC50
NOMESCO Finland
Cryotherapy
3.2
6.5
31
98
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
70.2
6.4
7
*
X76
ICPC
Malignant neoplasm breast female
70.2
6.4
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.2
6.4
7
*
R18
ICD-10 Finland
Ascites
4.9
6.4
19
39
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
6.3
73
370
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.1
6.3
11
10
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.3
406
3242
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
6.3
102
587
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
C02KX04
ATC
macitentan; oral
+∞
6.3
6
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
D69.1
ICD-10 Finland
Qualitative platelet defects
26.8
6.2
8
*
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
7.1
6.2
14
20
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.8
6.2
24
64
N02BE01
ATC
paracetamol; systemic, rectal
1.4
6.1
878
8014
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
376
106
50.54
307.65
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
221
62
43.19
307.65
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
243
122
24.55
307.65
1.6
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
439
163
41.22
307.65
1.3
1.2
u/l
18.5
21.8
0.20
333
142
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
817
958
23.21
307.65
10.1
2.6
u/l
292.9
237.4
16.21
805
899
(21494434) Karyotype in Bone marrow
162
78
23.75
219.04
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
435
892
6.98
217.75
3.9
2.2
e9/l
88.2
68.2
19.62
320
689
(3027945) Reticulocytes/100 erythrocytes in Blood
506
1210
6.39
215.64
4.2
2.0
%
2.0
1.8
3.94
451
1062
(3026493) Urate [Moles/volume] in Serum or Plasma
756
2621
5.85
209.82
5.2
2.4
umol/l
2297.1
7637.1
3.65
714
2215
(3017181) Myelocytes/100 leukocytes in Blood
376
691
7.38
208.85
10.5
3.6
%
0.9
0.7
0.68
190
146
(3022096) Basophils/100 leukocytes in Blood
945
4116
6.50
195.63
17.4
5.4
%
1.2
0.7
39.67
921
3779
(3006504) Eosinophils/100 leukocytes in Blood
954
4240
6.48
191.21
17.6
5.4
%
2.6
3.0
5.76
930
3884
(42870588) Differential panel, method unspecified - Blood
798
3066
5.52
190.73
16.8
5.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
343
631
7.14
188.97
10.4
3.6
%
0.8
0.6
0.44
141
108
(3019069) Monocytes/100 leukocytes in Blood
951
4259
6.35
187.49
18.7
5.7
%
7.6
8.8
23.18
927
3920
(3021440) Promyelocytes/100 leukocytes in Blood
349
660
6.97
187.02
10.4
3.7
%
0.2
0.1
1.86
186
131
(3002030) Lymphocytes/100 leukocytes in Blood
953
4333
6.24
182.70
18.3
5.5
%
21.6
26.9
40.26
928
3969
(3018010) Neutrophils/100 leukocytes in Blood
943
4297
6.04
178.83
16.5
5.4
%
64.9
57.9
49.45
916
3955
(3006315) Basophils [#/volume] in Blood
973
4572
6.30
177.12
15.7
5.2
e9/l
0.1
0.0
49.81
905
3875
(3001604) Monocytes [#/volume] in Blood
969
4551
6.23
176.08
15.6
5.2
e9/l
0.7
0.6
1.36
902
3844
(3013115) Eosinophils [#/volume] in Blood
984
4731
6.30
172.27
17.5
5.3
e9/l
0.3
0.2
3.24
924
4070
(3019198) Lymphocytes [#/volume] in Blood
973
4648
6.14
171.27
16.1
5.2
e9/l
2.0
1.8
0.32
920
4005
(3004809) Band form neutrophils/100 leukocytes in Blood
142
92
17.31
166.69
8.4
2.9
%
1.4
1.3
0.13
101
66
(3025159) Blasts/100 leukocytes in Blood
319
632
6.46
161.49
10.6
3.7
%
0.6
0.8
0.09
151
115
(3013650) Neutrophils [#/volume] in Blood by Automated count
998
5085
6.00
155.97
23.1
6.0
e9/l
6.5
4.3
26.36
941
4339
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
897
4679
4.34
122.72
10.3
3.8
umol/l
13.3
12.1
2.55
879
4357
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
410
1304
4.21
114.34
2.8
2.5
%
18.5
22.7
5.56
356
1091
(40760892) CBC W Ordered Manual Differential panel - Blood
494
1840
3.81
109.00
13.4
4.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
414
1401
3.94
104.61
2.6
2.4
g/l
2.6
2.3
17.47
391
1288
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
151
219
7.72
101.13
3.0
2.2
g/l
3.1
3.4
2.02
143
203
(3022948) Iron [Moles/volume] in Serum or Plasma
430
1539
3.75
99.34
2.7
2.4
umol/l
11.1
12.9
4.46
406
1404
(3017354) Segmented neutrophils/100 leukocytes in Blood
91
70
13.95
96.47
9.3
3.0
%
70.9
52.5
5.19
47
45
(4035726)
150
260
6.43
84.62
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
78
71
11.66
74.29
9.9
3.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
676
3837
2.68
62.63
3.7
2.7
ug/l
117.3
136.1
0.96
635
3464
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
118
225
5.69
59.87
2.6
2.0
%
91.4
86.4
1.43
105
216
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
95
146
6.97
59.80
4.8
3.0
%
65.9
58.6
3.98
95
146
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
170
461
4.12
56.21
1.8
1.6
g/l
1.0
1.5
13.84
149
403
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1014
7335
3.13
54.11
16.5
5.3
u/l
88.7
76.5
10.83
993
6743
(3021589) Normoblasts [#/volume] in Blood
678
4046
2.50
53.73
23.7
8.5
e9/l
0.0
0.0
3.52
613
3252
(40758558) Short blood count panel - Blood
433
2127
2.59
51.75
15.8
4.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
776
5002
2.48
50.80
8.1
5.6
mmol/l
1.2
1.2
0.36
653
4212
(3030905) Polymorphonuclear cells [#/volume] in Blood
86
143
6.39
50.10
3.6
2.9
e9/l
6.0
4.4
3.02
86
143
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
103
230
4.79
43.44
2.0
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
94
201
4.98
41.72
3.1
2.2
%
171.0
200.5
2.28
88
190
(3018418) pH of Serum or Plasma
506
2935
2.23
39.18
6.2
3.2
ph
7.4
7.4
2.90
103
493
(40765096) Chromosome analysis panel by Banding
32
19
17.26
38.54
1.1
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
127
5.78
37.23
5.6
5.1
iu/ml
505.7
473.8
—
6
18
(3024561) Albumin [Mass/volume] in Serum or Plasma
639
4159
2.11
35.84
6.4
3.7
g/l
35.5
35.3
0.29
604
3807
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
34
26
13.42
35.80
7.0
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
679
4530
2.11
35.55
7.4
5.2
mmol/l
1.2
1.2
0.92
620
3984
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
226
955
2.67
35.20
5.3
2.2
umol/l
7.6
8.4
0.39
203
820
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
450
2597
2.15
34.26
2.4
2.2
mg/l
8.1
2.9
26.83
385
2167
(3017732) Neutrophils [#/volume] in Blood
163
594
3.01
33.44
5.7
3.0
e9/l
6.7
4.1
5.83
107
420
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
368
1997
2.20
32.46
2.2
1.6
mg/l
1.2
1.3
0.50
288
1539
(3033658) Prothrombin time (PT) actual/Normal
392
2242
2.10
29.76
5.8
3.5
%
76.7
85.0
7.48
370
2178
(3013826) Glucose [Moles/volume] in Serum or Plasma
800
5885
2.02
29.60
5.8
4.5
mmol/l
6.6
6.9
3.30
771
5511
(3000093) Morphology [Interpretation] in Blood Narrative
50
83
6.24
29.08
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
99
299
3.51
27.56
3.1
1.8
s
22.4
21.4
0.64
89
269
(3012095) Magnesium [Moles/volume] in Serum or Plasma
278
1433
2.21
27.27
3.8
2.5
mmol/l
0.8
0.8
0.04
260
1302
(3018677) aPTT in Platelet poor plasma by Coagulation assay
283
1546
2.08
23.53
3.1
1.9
s
33.2
30.0
7.84
264
1488
(3003458) Phosphate [Moles/volume] in Serum or Plasma
249
1296
2.15
23.51
5.4
4.7
mmol/l
1.1
1.0
2.15
234
1180
(3032080) INR in Blood by Coagulation assay
601
4220
1.83
23.33
16.5
10.6
inr
1.5
1.4
1.89
193
1162
(3023368) Bacteria identified in Blood by Culture
422
2709
1.85
21.51
5.8
4.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
126
519
2.59
20.19
2.8
1.4
ug/l
20.8
3.8
0.49
100
391
(40768804) Tissue Pathology biopsy report
433
2856
1.79
19.85
2.4
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
147
662
2.39
19.45
1.4
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
158
738
2.31
19.22
2.0
1.9
g/l
0.2
0.2
0.10
147
660
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
120
4.30
19.21
2.1
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
134
589
2.43
18.69
2.3
2.1
g/l
10.7
10.9
0.17
119
533
(3021879) Hepatitis B virus core Ab [Presence] in Serum
106
418
2.68
18.52
1.2
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
409
2699
1.77
18.44
5.1
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
47
6.52
18.43
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
47
6.52
18.43
1.1
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
62
180
3.57
18.30
2.0
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
83
296
2.93
17.51
2.7
1.5
ratio
1.4
1.2
—
7
24
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
23
8
29.26
17.45
1.1
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
84
306
2.87
17.05
2.7
1.5
mg/l
30.4
35.6
0.76
72
242
(3020630) Protein [Mass/volume] in Serum or Plasma
164
824
2.14
16.60
2.8
1.6
g/l
66.3
66.9
0.52
155
733
(3034860) Kappa light chains.free [Mass/volume] in Serum
83
305
2.85
16.58
2.7
1.5
mg/l
83.7
45.2
0.43
70
241
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
149
725
2.20
16.34
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
58
174
3.45
16.30
2.2
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
30
54
5.67
16.07
1.8
1.7
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
18
10.13
15.83
1.4
1.1
%
64.0
82.4
—
10
8
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
18
10.13
15.83
1.4
1.1
%
67.3
87.1
—
10
8
(3048879) Bone marrow aspiration report
21
26
8.20
15.79
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
108
470
2.42
15.35
1.8
1.3
g/l
1.7
1.2
1.34
97
423
(3020779) Urea [Moles/volume] in Serum or Plasma
166
863
2.07
15.32
6.3
6.0
mmol/l
10.1
10.7
0.59
157
809
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
10
14.15
15.06
1.1
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
142
700
2.16
15.04
1.4
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
19
22
8.76
15.04
1.5
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
197
1096
1.95
15.01
2.1
1.7
—
—
—
0
0
(4212803)
19
6
32.12
14.82
1.1
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
96
403
2.50
14.75
2.4
1.7
ug/l
1.2
1.6
0.39
83
351
(40760888) Immunoglobulin light chains.free panel - Serum
65
223
3.02
14.69
2.8
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
19
23
8.37
14.53
1.0
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
873
7303
1.67
14.46
5.1
4.2
mm/h
8.6
12.9
17.85
824
6683
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
18
5
36.49
14.46
1.1
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
272
1697
1.77
14.35
2.1
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
150
775
2.06
14.03
3.0
2.8
mmol/l
1.2
1.2
2.05
124
645
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
31
6.87
13.61
2.6
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
31
6.87
13.61
2.6
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
31
6.87
13.61
2.6
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
31
6.87
13.61
2.6
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
315
2.61
13.50
4.6
2.6
u/ml
0.4
0.4
0.01
49
185
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
543
4100
1.58
13.44
6.6
3.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
58
198
3.02
13.24
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
592
4588
1.56
12.89
2.3
2.1
pmol/l
87.9
94.3
3.02
395
2257
(3008536) Aspergillus sp Ab [Presence] in Serum
13
11
11.93
12.65
3.4
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
312
2092
1.66
12.44
5.2
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
383
2717
1.59
12.09
1.8
1.5
nmol/l
18.4
20.8
2.39
343
2244
(3002582) Erythrocytes [#/volume] in Urine
404
2922
1.57
11.65
3.7
3.1
e6/l
42.8
79.9
0.72
321
2253
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
21
7.71
11.44
3.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
21
7.71
11.44
3.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
21
7.71
11.44
3.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
436
3219
1.55
11.43
3.3
2.1
mmol/l
2.3
2.4
2.00
375
2625
(3037756) Immunofixation for Serum or Plasma
54
193
2.88
11.39
1.2
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
127
674
1.99
10.98
2.2
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
409
3004
1.54
10.85
2.9
2.3
u/l
52.5
57.5
2.55
373
2744
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
99
3.61
10.80
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
51
4.78
10.74
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
130
3.23
10.62
1.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
133
728
1.93
10.51
4.5
3.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
52
4.69
10.50
2.4
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
133
730
1.92
10.42
2.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
65
4.22
10.39
2.4
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
65
4.22
10.39
2.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
65
4.22
10.39
2.4
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
459
3488
1.50
10.24
3.8
3.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
108
3.40
10.18
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
359
2592
1.54
10.18
3.6
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
280
1913
1.60
10.09
3.1
2.6
mosm/kgh2o
542.2
545.7
0.09
246
1596
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
39
5.20
9.85
3.0
1.5
e6/l
6278.6
984.3
—
8
16
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
381
2812
1.51
9.67
4.8
2.6
u/l
32.5
33.8
0.36
364
2657
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
78
3.78
9.63
1.8
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
335
2412
1.53
9.52
4.0
3.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
75
3.80
9.36
2.5
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
41
4.94
9.33
1.6
2.7
u/ml
1229.8
1155.5
0.06
20
41
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
141
2.97
9.30
1.5
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
459
3541
1.47
9.28
3.7
3.0
ng/l
2041.8
1613.3
1.08
401
3030
(3018095) Leukocytes [#/volume] in Urine
444
3412
1.47
9.12
4.3
3.6
e6/l
136.1
114.7
0.18
336
2432
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
39
132
3.02
9.10
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
363
2681
1.50
9.08
3.6
3.0
e6/l
0.5
0.4
0.14
281
2036
(3012501) Base excess in Blood by calculation
51
200
2.62
9.07
5.3
4.3
mmol/l
2.8
2.9
0.05
37
129
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
14
9
15.71
9.04
3.4
1.0
u/ml
44.2
17.4
—
14
9
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
33
102
3.30
8.94
1.1
1.1
u/ml
2.8
1.7
0.55
12
27
(3011412) CD3 cells [#/volume] in Blood
20
43
4.71
8.84
4.0
2.3
e9/l
0.7
1.1
—
9
24
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
691
5796
1.44
8.76
4.0
3.0
u/l
63.5
49.4
3.18
651
5277
(1616796) Gas panel - Central venous blood
49
193
2.60
8.65
3.7
3.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
131
2.96
8.60
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
83
413
2.08
8.58
2.4
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
183
1168
1.67
8.58
1.3
1.3
titre
525.0
581.6
0.12
32
269
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
171
2.69
8.52
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
290
2073
1.52
8.39
3.0
2.4
e6/l
3.8
5.5
2.39
256
1801
(3042936) Bacteria identified in Isolate by Culture
202
1331
1.62
8.34
2.1
2.1
—
—
—
0
0
(4306422)
32
102
3.19
8.27
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
24
63
3.87
8.26
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
82
3.47
8.25
2.5
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1047
9579
1.61
8.21
28.6
13.8
mg/l
18.9
24.5
9.16
925
7519
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
521
4186
1.42
8.19
4.7
4.0
ng/l
55.2
62.3
0.12
416
3114
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
18
38
4.79
8.13
2.6
1.9
nmol/l
2.2
3.6
1.40
18
38
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
31
99
3.19
7.99
1.1
1.2
u/ml
3.2
6.1
0.63
18
45
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
109
615
1.85
7.85
4.3
3.4
mmol/l
2.4
1.9
0.51
78
452
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
114
653
1.82
7.82
4.2
3.5
kpa
5.3
5.2
0.39
104
603
(3036481) Cortisol [Moles/volume] in Serum or Plasma
136
823
1.73
7.74
2.1
1.7
nmol/l
409.7
364.8
1.33
127
732
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
44
4.37
7.70
1.4
2.3
%
23.8
44.3
—
5
18
(21494890) Protein electrophoresis panel - 24 hour Urine
28
86
3.31
7.69
1.8
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
158
999
1.67
7.65
4.1
3.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
141
867
1.71
7.58
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
76
384
2.04
7.56
1.9
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
22
5.96
7.39
1.2
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
110
640
1.79
7.17
4.3
3.4
ph
7.4
7.4
0.01
13
74
(3007566) Smooth muscle Ab [Titer] in Serum
52
232
2.30
7.07
1.2
1.1
titre
50.0
91.5
—
5
20
(3037467) Urinalysis macro (dipstick) panel - Urine
775
6767
1.39
7.02
5.1
4.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
496
4029
1.39
7.00
2.4
2.3
nmol/l
76.9
79.1
0.92
446
3471
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
130
800
1.70
6.97
3.7
2.5
ml/min/173m2
53.3
63.0
3.38
84
327
(40768443) Skin Pathology biopsy report
70
355
2.03
6.91
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
159
1034
1.62
6.88
5.1
3.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
103
2.96
6.88
1.7
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
131
2.72
6.87
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
47
204
2.36
6.81
2.3
1.8
u/ml
102.3
74.5
0.12
36
157
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
37
144
2.62
6.74
1.1
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
14
7.19
6.70
1.1
1.3
—
—
—
0
0
(4268621)
23
69
3.38
6.57
1.9
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
163
1079
1.59
6.55
1.8
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
123
2.73
6.54
1.2
1.1
u/ml
380.9
294.3
0.57
19
65
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
378
1.96
6.47
2.8
1.4
g/l
3.3
3.1
0.55
55
287
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
414
1.92
6.46
2.7
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
414
1.92
6.46
2.7
1.4
g/l
3.4
3.9
2.47
55
284
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
414
1.92
6.46
2.7
1.4
g/l
6.8
7.5
3.28
56
292
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
60
3.54
6.45
2.1
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
387
1.94
6.38
2.8
1.4
g/l
10.9
10.6
0.18
59
319
(3021601) Nitrite [Presence] in Urine by Test strip
569
4773
1.36
6.38
6.0
5.1
estimate
0.0
0.0
0.00
154
785
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
108
2.82
6.35
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
131
2.64
6.33
1.5
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
567
4759
1.35
6.31
4.3
3.8
estimate
0.0
0.0
0.00
162
791
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
22
5.50
6.29
2.0
2.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
26
5.04
6.23
1.5
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
65
335
1.99
6.17
3.0
1.4
g/l
1.1
0.5
0.68
55
282
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
59
294
2.06
6.14
2.9
1.4
g/l
0.0
0.0
0.59
53
265
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
176
2.38
6.12
1.4
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
19
5.83
6.11
1.3
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
116
718
1.68
6.09
5.3
5.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
78
3.12
6.06
1.1
1.2
u/l
52.2
55.8
0.14
16
52
(3009261) Glucose [Presence] in Urine by Test strip
572
4830
1.34
6.02
4.4
3.8
estimate
0.0
0.0
0.50
156
772
(3019309) Folate [Moles/volume] in Red Blood Cells
295
2244
1.41
5.96
1.8
1.8
nmol/l
1033.0
1174.7
1.91
231
1670
(40758292) HTLV I+II Ab panel - Serum
9
6
15.09
5.91
1.3
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
6
15.09
5.91
5.7
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
254
1887
1.44
5.85
3.5
2.2
mmol/l
2.4
2.5
0.17
224
1606
(40767503) Oxygen content in Capillary blood by calculation
44
199
2.26
5.84
2.8
2.4
%
17.4
16.4
0.43
21
100
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
125
2.60
5.82
1.5
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
20
5.54
5.81
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
127
2.56
5.65
1.3
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
17
5.92
5.63
2.9
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
61
3.32
5.59
1.2
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
734
6471
1.33
5.57
5.4
4.6
e6/l
14.9
2073.3
—
7
102
(3026008) Bacteria identified in Urine by Culture
394
3194
1.34
5.28
3.7
3.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
213
1559
1.44
5.28
38.5
28.9
inr
1.6
1.4
0.73
33
211
(3007164) IgA [Mass/volume] in Serum or Plasma
214
1569
1.44
5.26
1.5
1.3
g/l
2.5
2.7
0.67
140
872
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
54
277
1.99
5.23
3.1
1.4
g/l
0.0
0.0
0.00
49
252
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
106
668
1.64
5.22
1.8
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
443
3660
1.33
5.20
4.6
4.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
35
4.03
5.17
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
57
301
1.94
5.09
1.4
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
54
281
1.96
5.04
3.1
1.4
g/l
0.0
0.0
0.00
49
253
(3013512) EKG study
386
3138
1.33
5.03
4.9
4.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
23
4.82
5.02
1.2
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
170
1203
1.48
5.01
2.0
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
60
325
1.89
4.98
2.9
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
978
9063
1.38
4.95
27.6
12.8
ml/min/173m2
73.6
74.8
1.06
873
7269
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
460
1.74
4.92
2.7
2.9
pmol/l
4.3
4.4
0.81
66
390
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
24
4.62
4.78
1.1
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
20
5.03
4.78
1.2
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
20
5.03
4.78
1.7
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
59
323
1.87
4.75
2.9
1.4
g/l
38.5
37.5
0.56
52
263
(3000991) Gas panel - Venous blood
123
823
1.55
4.73
4.4
7.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
58
3.13
4.65
1.5
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
29
4.17
4.63
2.6
2.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
167
1197
1.46
4.61
5.9
7.1
mmol/l
1.0
1.3
0.36
123
923
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
167
1197
1.46
4.61
5.7
7.1
kpa
4.9
5.1
1.25
158
1146
(3027801) Oxygen [Partial pressure] in Arterial blood
167
1197
1.46
4.61
5.7
7.1
kpa
10.8
11.5
1.01
158
1145
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
5
14.07
4.58
1.0
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
70
2.89
4.50
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
87
2.67
4.50
1.1
1.6
—
—
—
0
0
(44806118)
24
94
2.58
4.40
1.8
1.5
—
—
—
0
0
(44790049)
24
94
2.58
4.40
1.8
1.5
—
—
—
0
0
(44790047)
24
94
2.58
4.40
1.8
1.5
—
—
—
0
0
(44790048)
24
94
2.58
4.40
1.8
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
113
2.42
4.33
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
49
261
1.91
4.31
1.4
1.6
iu/ml
1.1
0.1
—
9
60
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
158
2.18
4.30
2.1
2.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
321
2592
1.32
4.29
4.5
4.0
estimate
0.0
0.0
0.50
152
763
(3021901) Oxygen saturation in Capillary blood
38
185
2.09
4.28
3.2
2.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
6
11.72
4.28
1.1
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
166
1208
1.43
4.23
2.0
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
118
807
1.51
4.12
2.2
2.1
u/l
33.9
39.9
0.45
97
656
(3052851) Hemolysis interference index of Serum or Plasma
53
295
1.83
4.09
2.8
3.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
39
196
2.02
4.06
1.3
1.3
mmol/l
61.1
64.4
0.21
31
157
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
992
9301
1.34
3.98
5.3
4.3
mmol/l
1.3
1.3
0.97
940
8344
(3002385) Erythrocyte distribution width [Ratio]
842
7724
1.28
3.98
42.4
16.6
%
16.7
13.7
121.32
835
7488
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
119
2.30
3.89
1.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
76
476
1.64
3.89
4.9
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
142
1022
1.44
3.85
4.1
3.1
mmol/l
1.7
2.1
0.77
115
817
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
29
134
2.19
3.75
1.1
1.3
nmol/l
0.6
0.7
0.42
29
125
(3022145) Colonoscopy Study observation
127
901
1.46
3.72
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
203
1.95
3.71
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
38
196
1.97
3.70
2.3
2.9
umol/l
30.1
35.6
0.91
31
169
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
66
405
1.67
3.67
4.9
3.7
mmol/l
24.4
24.9
0.63
59
368
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
16
5.66
3.66
5.4
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
110
2.30
3.63
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
171
1287
1.38
3.60
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
92
2.42
3.57
2.5
2.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
9
7.81
3.56
1.1
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
146
1074
1.41
3.52
6.2
7.4
%
94.2
95.0
0.51
141
1038
(40765089) Chromosome analysis panel - Blood by G-banded
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
117
831
1.45
3.42
3.5
3.6
ng/l
89.8
93.0
0.16
100
711
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
10
7.03
3.36
1.3
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
22
95
2.34
3.35
1.1
1.6
e6/l
21145.6
95326.8
—
9
55
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
43
240
1.82
3.34
2.3
2.1
mg/l
13.6
12.0
0.48
37
221
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
7
8.61
3.26
1.2
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
43
3.04
3.25
1.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
9
19
4.76
3.24
1.0
1.5
g/l
15.6
11.9
—
9
12
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
197
1541
1.33
3.23
3.6
2.8
e6/l
1.5
2.7
2.84
113
842
(40768800) Prostate Pathology biopsy report
17
66
2.60
3.22
1.2
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
11
6.39
3.18
2.7
4.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
53
321
1.68
3.13
1.2
1.2
u/ml
0.2
0.5
—
5
29
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
39
3.10
3.09
1.4
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
39
3.10
3.09
1.4
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
119
2.12
3.05
1.1
1.3
nmol/l
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
5
10.03
2.98
1.0
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
23
107
2.17
2.98
1.0
1.6
e6/l
2864.1
1706.2
0.36
12
79
(40757373) Influenza virus identified in Isolate
10
30
3.35
2.91
1.5
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
14
5.02
2.73
1.7
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
14
5.02
2.73
1.7
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
265
2204
1.26
2.71
1.4
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
24
3.77
2.67
1.6
2.2
mmol/l
1.2
1.2
—
9
24
(3017446) Testosterone [Moles/volume] in Serum or Plasma
82
573
1.46
2.65
3.5
2.2
nmol/l
13.6
14.9
0.70
76
500
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
87
615
1.45
2.65
1.8
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
207
1676
1.28
2.64
3.4
2.6
e6/l
0.6
1.5
2.96
121
973
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
49
2.67
2.62
1.4
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
15
4.69
2.60
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
20
4.02
2.57
2.8
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
390
3399
1.22
2.56
2.3
2.2
u/l
153.4
232.1
1.61
360
3172
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
208
1.75
2.56
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
945
8954
1.24
2.55
5.3
4.7
mu/l
2.1
2.1
0.11
897
8046
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
5
7
7.17
2.55
1.4
1.7
%
2.1
1.9
—
5
7
(3025941) Bacteria identified in Stool by Culture
65
437
1.51
2.55
1.4
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
88
2.18
2.51
1.2
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
75
2.28
2.51
1.1
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
791
7372
1.20
2.50
4.2
3.8
pmol/l
15.0
15.0
0.05
732
6589
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
16
4.39
2.47
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
40
241
1.68
2.46
1.8
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
128
982
1.34
2.42
6.4
7.8
g/l
127.2
121.4
1.67
122
950
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
183
1.77
2.37
1.4
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
8
6.27
2.37
1.4
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
71
2.27
2.35
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
47
2.57
2.27
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
47
2.57
2.27
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
58
391
1.51
2.27
2.2
1.9
u/l
40.1
39.3
0.10
49
330
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
18
3.90
2.25
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1064
10255
1.27
2.23
30.4
16.9
mmol/l
139.4
139.7
3.57
1050
9959
(3016038) Potassium [Moles/volume] in Urine
17
80
2.14
2.19
1.1
1.2
mmol/l
33.1
33.7
0.03
17
70
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
48
2.51
2.19
2.1
1.9
nmol/l
17.3
17.9
0.12
12
38
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
572
0.62
2.17
2.2
1.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
44
282
1.58
2.16
4.0
3.4
nmol/l
0.8
0.8
0.17
32
223
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
255
2164
1.22
2.16
3.8
4.1
ng/l
143.0
484.2
3.30
199
1826
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
116
1.91
2.11
2.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
22
116
1.91
2.11
2.3
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
65
456
1.45
2.11
5.2
5.5
%
1.9
1.6
0.88
59
437
(3049717) Cytology report of Urine Cyto stain
49
325
1.53
2.09
2.2
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
29
168
1.74
2.09
1.1
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
110
1.92
2.06
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
56
2.34
2.05
1.5
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
56
2.34
2.05
1.9
2.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
69
2.19
2.05
1.5
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
50
2.41
2.03
1.6
1.5
u/l
1.7
10.2
—
7
23
(3019420) Tryptase [Mass/volume] in Serum or Plasma
10
38
2.64
2.01
1.4
1.6
ug/l
14.0
14.3
—
10
31
(3006184) Hemoglobin [Mass/volume] in Capillary blood
36
225
1.62
1.98
2.0
2.1
g/l
140.0
131.4
0.71
28
167
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
64
2.20
1.94
1.1
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
16
3.76
1.93
2.0
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1063
10280
1.24
1.92
32.1
17.0
mmol/l
4.0
4.0
5.45
1049
9964
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
78
2.07
1.91
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
532
4864
1.16
1.90
2.5
2.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
121
1.83
1.89
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
114
1.86
1.88
2.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
40
2.51
1.84
1.7
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
40
2.51
1.84
1.7
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
116
1.82
1.79
2.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
22
124
1.79
1.76
2.3
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
997
9601
1.20
1.76
5.7
4.8
mmol/l
1.2
1.4
42.31
947
8697
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
81
1.99
1.75
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
753
7953
0.86
1.74
47.4
18.5
g/l
320.1
332.2
53.85
746
7874
(3009542) Hematocrit [Volume Fraction] of Blood
883
8423
1.17
1.72
35.6
15.5
%
40.6
39.4
1.93
527
5393
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
382
0.59
1.71
1.9
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
68
2.07
1.70
1.4
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
55
2.19
1.67
1.6
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
44
301
1.48
1.67
1.4
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
25
2.81
1.65
2.7
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1005
9701
1.19
1.64
5.8
4.8
mmol/l
4.0
4.5
53.59
962
8851
(3008152) Bicarbonate [Moles/volume] in Arterial blood
91
708
1.31
1.63
9.6
7.3
mmol/l
23.7
24.5
0.90
84
663
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
14
3.58
1.61
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
113
1.78
1.61
2.4
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
43
2.34
1.60
1.3
1.3
—
—
—
0
0
(4281824)
10
43
2.34
1.60
1.2
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
43
2.34
1.60
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
1061
1.25
1.60
1.3
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
26
2.70
1.58
2.7
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
50
2.21
1.57
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
114
1.77
1.57
2.4
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
13
64
2.04
1.54
1.2
1.6
—
15.5
—
0
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
21
2.87
1.50
1.2
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
110
889
1.26
1.49
1.7
1.8
%
1.5
1.6
0.43
93
749
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
69
524
1.34
1.48
7.2
10.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
38
2.38
1.45
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1060
10308
1.20
1.45
24.6
9.3
u/l
25.3
25.5
0.12
1042
9826
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
52
2.13
1.44
1.2
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
60
448
1.36
1.44
5.7
5.6
%
1.0
0.9
1.03
55
429
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
39
2.32
1.43
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
40
2.26
1.40
1.3
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
29
2.42
1.39
1.3
1.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
80
627
1.30
1.39
5.8
8.4
%
0.7
0.7
0.32
80
622
(4034850)
24
371
0.64
1.37
21.5
11.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
129
1073
1.23
1.36
3.8
3.2
ng/l
279.3
231.9
0.47
118
983
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
17
2.95
1.36
1.0
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
508
0.70
1.31
1.5
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
24
2.51
1.30
1.7
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
43
2.10
1.30
1.3
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
114
1.68
1.28
2.7
3.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
27
178
1.53
1.27
2.2
1.9
pmol/l
188.8
214.6
0.48
27
167
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
146
1.59
1.26
3.1
2.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
19
115
1.66
1.25
1.1
1.0
g/l
1.5
1.5
0.18
19
99
(3036048) Francisella tularensis Ab [Titer] in Serum
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
58
1.90
1.12
1.5
1.3
g/l
0.9
1.0
0.48
11
58
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
23
152
1.52
1.09
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
21
2.39
1.09
1.2
2.6
—
—
—
0
0
(3020891) Body temperature
57
444
1.30
1.08
5.9
4.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
966
9382
1.14
1.08
6.8
6.5
mmol/mol
38.6
40.8
12.27
925
8605
(36660697) Celiac disease serology panel - Serum
82
670
1.24
1.06
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
39
288
1.37
1.06
1.2
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
72
580
1.26
1.06
4.1
3.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
46
1.96
1.03
2.4
4.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
22
2.28
1.03
1.2
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
22
2.28
1.03
1.4
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
44
333
1.33
1.03
2.6
2.4
g/l
0.5
0.2
0.77
18
107
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
34
2.06
1.03
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
84
1.67
0.98
1.1
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
31
0.00
0.96
0.0
1.3
—
116.3
—
0
26
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
31
0.00
0.96
0.0
1.4
—
28.8
—
0
22
(3008898) HLA-B27 [Presence]
15
234
0.64
0.95
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
153
1342
1.16
0.94
5.0
4.9
%
31.0
33.0
1.82
125
867
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
101
1.59
0.93
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
27
2.23
0.93
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
32
235
1.37
0.92
1.1
1.2
—
3.3
—
0
25
(3026389) Candida sp identified in Specimen by Organism specific culture
19
127
1.50
0.89
1.7
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
10
56
1.79
0.88
1.3
7.0
—
72.2
—
0
17
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
45
1.78
0.84
1.1
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
64
525
1.23
0.84
2.9
2.3
%
1.3
1.2
0.47
64
520
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
32
1.88
0.82
5.7
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
32
1.88
0.82
5.7
2.8
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
8
47
1.71
0.80
3.4
2.2
umol/l
65.2
51.3
—
8
34
(3004451) EKG impression Narrative
10
58
1.73
0.79
1.2
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
140
1.44
0.77
1.2
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
24
174
1.39
0.77
1.1
1.2
—
49.2
—
0
19
(3045414) Leukocytes [Presence] in Urine
54
440
1.24
0.77
2.2
2.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1015
9945
1.12
0.77
6.3
5.4
mmol/l
2.3
2.6
39.26
968
9032
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
28
0.00
0.76
0.0
2.6
—
8.7
—
0
13
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
244
0.69
0.76
1.5
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
54
1.67
0.74
1.1
1.1
mg/l
41.0
33.1
—
9
47
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
9
54
1.67
0.74
2.1
1.5
u/field
2.4
3.2
—
9
42
(3022621) pH of Urine by Test strip
81
691
1.18
0.74
3.6
3.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
33
254
1.31
0.74
1.1
1.2
—
32.8
—
0
12
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
39
1.80
0.72
1.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
56
1.61
0.72
1.3
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
37
291
1.28
0.71
5.1
4.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
7
40
1.75
0.71
7.7
7.9
%
65.1
74.7
—
7
35
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
26
1.93
0.70
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
212
1.33
0.70
2.1
1.3
—
—
—
0
0
(4027681)
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
273
0.73
0.68
1.8
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
43
1.63
0.67
2.9
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
400
3784
1.08
0.67
4.6
3.9
ug/l
2.0
2.0
0.04
360
3371
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
127
0.63
0.64
2.4
1.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
29
1.73
0.64
1.6
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
29
1.73
0.64
1.6
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
49
1.64
0.62
3.0
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
8
51
1.57
0.60
1.0
1.4
—
—
—
0
0
(44813793)
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
90
793
1.15
0.58
1.7
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
35
1.72
0.57
1.3
1.2
—
56.5
—
0
8
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
60
513
1.18
0.57
2.8
2.3
%
0.7
0.7
0.39
60
489
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
36
1.67
0.56
1.8
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
36
1.67
0.56
1.2
1.2
iu/ml
221.9
248.6
—
6
36
(3014271) Vancomycin [Susceptibility]
10
65
1.54
0.55
3.4
2.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
42
350
1.21
0.53
8.3
7.2
mmol/l
1.4
1.3
0.32
36
314
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
62
1.45
0.53
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
62
1.45
0.53
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
62
1.45
0.53
1.0
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
62
1.45
0.53
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
117
1.37
0.52
1.9
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
9
63
1.43
0.52
1.0
1.3
—
—
—
0
0
(4010399)
84
744
1.14
0.52
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
198
2128
0.92
0.52
2.8
2.7
ug/l
0.8
0.7
0.07
140
1434
(3019150) Specific gravity of Urine by Refractometry
211
2261
0.92
0.51
4.9
4.2
kg/l
1.0
1.0
0.08
39
334
(3012565) Volume of 24 hour Urine
6
40
1.50
0.51
2.0
2.0
ml
2583.3
1932.9
—
6
33
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
390
0.82
0.50
1.5
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
45
1.56
0.49
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
107
967
1.12
0.49
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
110
0.63
0.48
2.4
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
93
1.40
0.48
2.4
3.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
162
1501
1.09
0.46
1.2
1.2
u/ml
8.1
12.8
0.54
62
541
(3039443) Prostate specific Ag panel - Serum or Plasma
13
176
0.74
0.46
1.4
1.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
81
0.62
0.46
2.2
2.0
ug/l
8.7
3.2
—
5
76
(3025577) Chromium [Mass/volume] in Blood
5
81
0.62
0.46
2.0
2.1
ug/l
3.6
2.0
—
5
71
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
333
3487
0.94
0.44
3.2
3.2
mmol/l
7.0
7.3
0.45
274
2915
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
120
1099
1.10
0.44
2.1
2.5
ug/l
4.7
7.5
2.34
87
958
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
31
1.62
0.43
1.2
1.5
%
59.8
53.8
—
5
25
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
113
1.33
0.42
1.1
1.1
—
20.6
—
0
5
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
2.4
2.7
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
1.0
1.7
umol/l
9.8
14.0
—
8
55
(3051593) INR in Capillary blood by Coagulation assay
10
71
1.41
0.39
2.3
13.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
196
1847
1.07
0.38
1.3
1.2
u/ml
0.7
1.7
2.86
39
482
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
89
975
0.91
0.37
1.6
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
103
947
1.10
0.37
2.4
2.1
ug/g
157.6
163.7
0.06
87
740
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
272
1.18
0.36
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
80
0.62
0.35
1.4
1.5
—
56.7
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
189
0.79
0.34
1.4
1.4
—
—
—
0
0
(4062490)
11
82
1.34
0.34
1.2
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
30
256
1.18
0.33
1.5
1.4
ug/g
316.3
300.1
0.14
16
148
(3025130) Human papilloma virus identified in Specimen
6
46
1.31
0.33
1.3
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
275
1.17
0.33
1.3
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
41
360
1.14
0.32
1.1
1.1
—
219.0
—
0
9
(3021387) Prolactin [Units/volume] in Serum or Plasma
17
137
1.24
0.32
2.3
1.7
mu/l
270.2
269.7
0.00
17
127
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
220
1.19
0.32
1.7
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
220
1.19
0.32
1.7
1.4
—
—
—
0
0
(4024509)
13
101
1.29
0.31
1.3
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1005
9943
1.06
0.31
27.8
13.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
75
1.34
0.30
1.1
1.0
mg/l
302.0
283.7
—
10
67
(42529406) Shigella sp [Presence] in Stool by Culture
32
278
1.16
0.29
1.3
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
34
297
1.15
0.29
2.7
2.3
ug/min
226.8
65.8
0.62
20
184
(3011397) Hemoglobin [Presence] in Urine by Test strip
250
2401
1.05
0.28
4.2
3.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
984
9740
1.05
0.28
5.4
5.0
mmol/l
6.0
6.1
0.61
910
8744
(3032773) Endomysium IgG Ab [Titer] in Serum
8
63
1.27
0.27
1.3
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
28
244
1.15
0.26
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
114
1.23
0.25
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
87
1.27
0.24
1.1
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
723
7123
1.04
0.24
4.8
4.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
82
0.73
0.24
1.3
1.5
—
224.5
—
0
11
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
59
543
1.09
0.23
1.3
1.3
—
49.4
—
0
20
(4146454)
10
125
0.80
0.23
3.0
2.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
92
0.76
0.22
1.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
10
79
1.27
0.22
1.0
1.1
—
5.4
—
0
5
(3044927) Protein electrophoresis panel - Urine
16
135
1.19
0.21
1.4
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
11
0.00
0.21
0.0
1.6
—
22.6
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
61
566
1.08
0.21
2.6
2.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.6
—
0
5
(3007461) Platelets [#/volume] in Blood
1072
10654
1.05
0.20
52.2
20.1
e9/l
374.9
243.0
98.24
1055
10285
(3006653) Thiamine [Moles/volume] in Blood
6
49
1.23
0.20
3.3
1.3
nmol/l
274.0
147.0
—
6
49
(3013139) Helicobacter pylori Ag [Presence] in Stool
56
603
0.93
0.20
1.2
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
1072
10655
1.05
0.19
51.9
20.1
fl
90.7
91.5
1.54
1063
10428
(3035941) MCH [Entitic mass]
1072
10656
1.05
0.19
51.8
20.1
pg
29.1
30.5
15.22
1063
10429
(40761535) Cells panel - Urine sediment
97
920
1.06
0.19
4.1
3.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1072
10657
1.04
0.19
52.1
20.2
e12/l
4.8
4.5
26.26
1049
10246
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
353
0.90
0.19
1.5
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1072
10658
1.04
0.18
52.2
20.2
e9/l
10.2
6.8
26.40
1051
10251
(3000963) Hemoglobin [Mass/volume] in Blood
1072
10659
1.04
0.18
52.4
20.3
g/l
135.1
135.4
0.19
1062
10434
(3028707) Methadone [Presence] in Urine by Screen method
7
58
1.21
0.18
1.7
2.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
58
1.21
0.18
1.1
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
7
59
1.19
0.18
1.3
1.4
u/l
7.4
6.3
—
7
52
(3014051) Protein [Presence] in Urine by Test strip
28
252
1.11
0.18
2.9
2.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
11
91
1.21
0.17
2.5
2.1
u/field
5.3
2.2
—
6
35
(3044242) Glucose [Moles/volume] in Arterial blood
5
67
0.75
0.17
1.8
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
68
0.73
0.17
2.4
2.1
—
144.5
—
0
17
(3004775) Volume in Urine collected for unspecified duration
12
101
1.19
0.16
2.4
2.5
ml
640.6
621.4
—
7
70
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
292
1.10
0.16
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
379
1.08
0.16
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
335
3419
0.97
0.15
3.3
3.2
mg/l
1250.5
185.0
1.57
215
2138
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
168
1.13
0.15
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
178
1.13
0.15
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
246
2400
1.03
0.15
1.7
1.7
pmol/l
56614269.5
19322115.5
0.29
189
1946
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
86
0.81
0.14
1.1
1.6
—
28.2
—
0
19
(3003740) Influenza virus B Ag [Presence] in Specimen
7
90
0.78
0.14
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
138
1427
0.96
0.14
9.1
7.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
159
1543
1.03
0.13
1.3
1.3
iu/ml
22.1
38.2
2.13
56
484
(3023419) Bacteria identified in Sputum by Culture
17
151
1.13
0.13
3.0
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
355
3611
0.98
0.13
4.0
4.0
mg/mmol
16.6
8.1
1.22
227
2254
(3004716) Salmonella sp identified in Stool by Organism specific culture
40
376
1.07
0.11
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
268
2729
0.98
0.11
1.6
1.6
mmol/l
1.5
1.4
1.90
229
2247
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
495
1.05
0.10
1.2
1.2
iu/ml
105.1
126.0
0.18
19
195
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
164
1.10
0.09
1.6
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
87
1.15
0.09
1.2
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
10
87
1.15
0.09
1.0
1.1
—
73.2
—
0
10
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
421
0.95
0.09
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
319
0.94
0.09
1.6
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
301
3049
0.98
0.08
3.8
3.8
%
20.7
24.2
4.10
136
1457
(3038026) Centromere Ab [Units/volume] in Serum
10
88
1.14
0.08
1.0
1.1
—
89.0
—
0
5
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
67
1.05
0.08
1.0
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
6
70
0.86
0.07
1.5
1.2
u/ml
0.6
1.7
—
6
42
(3011288) Drugs identified in Urine by Screen method
8
76
1.05
0.07
2.3
3.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
82
0.85
0.07
1.1
1.7
%
14.7
10.7
—
7
82
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
132
0.91
0.06
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
303
3001
1.01
0.05
3.9
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
180
0.94
0.04
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
24
230
1.04
0.03
2.1
2.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
219
0.96
0.03
1.5
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
93
1.08
0.02
1.5
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
197
0.96
0.01
1.3
1.8
iu/l
3.9
4.8
—
8
61
(3027008) Opiates [Presence] in Urine
12
124
0.97
0.00
1.4
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
124
0.97
0.00
1.3
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
121
0.99
0.00
1.5
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
121
0.99
0.00
1.4
1.9
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
21
209
1.00
0.00
1.2
1.3
e6/l
97.4
798.8
0.79
14
178
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
209
1.00
0.00
1.1
1.3
e6/l
1.3
46.2
0.98
12
171
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
231
1.00
0.00
7.0
3.5
mg/l
22.0
27.7
0.42
15
155
(3021788) Differential panel - Synovial fluid
19
193
0.98
0.00
1.5
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
26
265
0.98
0.00
1.4
1.6
e6/l
13627.4
12686.0
0.05
18
194
(4094501)
28
285
0.98
0.00
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
29
290
1.00
0.00
1.1
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
12.0
—
0
6
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
61
0.98
0.00
1.0
1.7
—
73.2
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
370.3
—
0
6
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
111.3
—
0
7
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
3.2
—
896.8
—
0
5
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
1.5
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
2.4
—
633.0
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
71
0.99
0.00
2.6
2.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
10.9
—
0
6
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
1.3
—
0
5
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
19.6
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
69
0.87
0.00
1.5
1.2
mmol/l
2.1
2.0
—
6
64
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
120
1.00
0.00
1.4
1.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint POLYCYTVERA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| POLYCYTVERA | 2.079 [1.84, 2.35] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.027 |
During the follow-up period (1.1.1998 — 31.12.2019), 1275 out of 3089 females with POLYCYTVERA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| POLYCYTVERA | 1.913 [1.67, 2.19] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 1129 out of 2970 males with POLYCYTVERA died.
Mortality risk
Mortality risk for people of age
years, who have POLYCYTVERA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.135% | 0.366% |
| 5 | 0.975% | 2.055% |
| 10 | 2.376% | 5.434% |
| 15 | 4.47% | 10.324% |
| 20 | 8.094% | 16.756% |
Relationships between endpoints
↥Index endpoint: POLYCYTVERA – Polycythaemia vera
GWS hits: 12
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data